CD274 and breast cancer: Nevertheless, even with the development of new efficient therapies (immunotherapy with PDL1 inhibitors), BC recurrence and metastasis are still the leading causes of death [4], mainly because of the emergence of therapy-resistant cancer cells [5,6].